Skip to main content
NCBI home page
Gut logoLink to Gut
. 1989 Sep;30(9):1279–1284. doi: 10.1136/gut.30.9.1279

Carbohydrate digestion and release of pancreatic polypeptide in health and diabetes mellitus.

P Layer 1, V L Go 1, E P DiMagno 1
PMCID: PMC1434239  PMID: 2478426

Abstract

The effects of meal volume and luminal digestion of carbohydrates on the release of pancreatic polypeptide (HPP) were investigated in eight healthy subjects and in six patients who had non-insulin dependent diabetes mellitus. On one occasion each subject ingested a placebo with 200 ml water and a starch (50 g) pudding meal (400 ml) 30 minutes later. On another occasion an amylase inhibitor that retards intraluminal starch digestion was given with the water and starch. In normal subjects, water caused a moderate rise in HPP plasma levels (16.9 (10.9) pg/ml; p less than 0.02) and ingestion of starch increased HPP in a double peaked pattern. The mean increments of the peaks were 45.0 (15.2) pg/ml (p less than 0.02) and 41.1 (17.3) pg/ml (p less than 0.05), respectively. In the diabetic subjects, the HPP concentrations did not increase in response to water. After ingestion of starch the diabetics had two peaks of HPP that were similar in magnitude, but the early postprandial peak was delayed significantly compared to normal subjects (37.5 (5.1) min v 23.4 (3.9) min; p less than 0.05). The amylase inhibitor (5 or 10 g) reduced the early postprandial HPP peak by 79% (p less than 0.05) in normal subjects and 4 g of the inhibitor reduced the early HPP peak by 58% (p less than 0.05) in the diabetics. In both groups ingestion of the amylase inhibitor abolished the late HPP peak (p less than 0.05). In conclusion, carbohydrate induced HPP release is dependent on undisturbed intraluminal starch digestion.

Full text

PDF
1279

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adrian T. E., Besterman H. S., Cooke T. J., Bloom S. R., Barnes A. J., Russell R. C. Mechanism of pancreatic polypeptide release in man. Lancet. 1977 Jan 22;1(8004):161–163. doi: 10.1016/s0140-6736(77)91762-7. [DOI] [PubMed] [Google Scholar]
  2. Amland P. F., Jorde R., Aanderud S., Burhol P. G., Giercksky K. E. Effects of intravenously infused porcine GIP on serum insulin, plasma C-peptide, and pancreatic polypeptide in non-insulin-dependent diabetes in the fasting state. Scand J Gastroenterol. 1985 Apr;20(3):315–320. doi: 10.3109/00365528509091657. [DOI] [PubMed] [Google Scholar]
  3. Amland P. F., Jorde R., Burhol P. G., Giercksky K. E. Effects of atropine on GIP-induced insulin and pancreatic polypeptide release in man. Scand J Gastroenterol. 1985 Apr;20(3):321–324. doi: 10.3109/00365528509091658. [DOI] [PubMed] [Google Scholar]
  4. Boivin M., Flourie B., Rizza R. A., Go V. L., DiMagno E. P. Gastrointestinal and metabolic effects of amylase inhibition in diabetics. Gastroenterology. 1988 Feb;94(2):387–394. doi: 10.1016/0016-5085(88)90426-x. [DOI] [PubMed] [Google Scholar]
  5. Boivin M., Zinsmeister A. R., Go V. L., DiMagno E. P. Effect of a purified amylase inhibitor on carbohydrate metabolism after a mixed meal in healthy humans. Mayo Clin Proc. 1987 Apr;62(4):249–255. doi: 10.1016/s0025-6196(12)61900-4. [DOI] [PubMed] [Google Scholar]
  6. Christofides N. D., Sarson D. L., Albuquerque R. H., Adrian T. E., Ghatei M. A., Modlin I. M., Bloom S. R. Release of gastrointestinal hormones following an oral water load. Experientia. 1979 Nov 15;35(11):1521–1523. doi: 10.1007/BF01962823. [DOI] [PubMed] [Google Scholar]
  7. DiMagno E. P., Go V. L., Summerskill W. H. Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency. N Engl J Med. 1973 Apr 19;288(16):813–815. doi: 10.1056/NEJM197304192881603. [DOI] [PubMed] [Google Scholar]
  8. Fink A. S., Floyd J. C., Jr, Fiddian-Green R. G. Release of human pancreatic polypeptide and gastrin in response to intraduodenal stimuli: a case report. Metabolism. 1979 Apr;28(4):339–342. doi: 10.1016/0026-0495(79)90104-5. [DOI] [PubMed] [Google Scholar]
  9. Flaten O., Myren J. Adrenergic modulation of the release of pancreatic polypeptide after intraduodenal and oral glucose in man. Scand J Gastroenterol. 1981;16(6):781–787. doi: 10.3109/00365528109181004. [DOI] [PubMed] [Google Scholar]
  10. Flaten O., Tronier B. Dose-dependent increase in concentrations of gastric inhibitory polypeptide and pancreatic polypeptide after small amounts of glucose intraduodenally in man. Scand J Gastroenterol. 1982 Aug;17(5):677–680. doi: 10.3109/00365528209181078. [DOI] [PubMed] [Google Scholar]
  11. Floyd J. C., Jr, Fajans S. S., Pek S., Chance R. E. A newly recognized pancreatic polypeptide; plasma levels in health and disease. Recent Prog Horm Res. 1976;33:519–570. doi: 10.1016/b978-0-12-571133-3.50019-2. [DOI] [PubMed] [Google Scholar]
  12. Floyd J. C., Jr Pancreatic polypeptide. Clin Gastroenterol. 1980 Sep;9(3):657–678. [PubMed] [Google Scholar]
  13. Fogel M. R., Gray G. M. Starch hydrolysis in man: an intraluminal process not requiring membrane digestion. J Appl Physiol. 1973 Aug;35(2):263–267. doi: 10.1152/jappl.1973.35.2.263. [DOI] [PubMed] [Google Scholar]
  14. Hilsted J., Madsbad S., Krarup T., Tronier B., Galbo H., Sestoft L., Schwartz T. W. No response of pancreatic hormones to hypoglycemia in diabetic autonomic neuropathy. J Clin Endocrinol Metab. 1982 Apr;54(4):815–819. doi: 10.1210/jcem-54-4-815. [DOI] [PubMed] [Google Scholar]
  15. Krarup T., Schwartz T. W., Hilsted J., Madsbad S., Verlaege O., Sestoft L. Impaired response of pancreatic polypeptide to hypoglycaemia: an early sign of autonomic neuropathy in diabetics. Br Med J. 1979 Dec 15;2(6204):1544–1546. doi: 10.1136/bmj.2.6204.1544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Larsson L. I., Sundler F., Håkanson R. Pancreatic polypeptide - a postulated new hormone: identification of its cellular storage site by light and electron microscopic immunocytochemistry. Diabetologia. 1976 Jul;12(3):211–226. doi: 10.1007/BF00422088. [DOI] [PubMed] [Google Scholar]
  17. Layer P., Carlson G. L., DiMagno E. P. Partially purified white bean amylase inhibitor reduces starch digestion in vitro and inactivates intraduodenal amylase in humans. Gastroenterology. 1985 Jun;88(6):1895–1902. doi: 10.1016/0016-5085(85)90016-2. [DOI] [PubMed] [Google Scholar]
  18. Layer P., Rizza R. A., Zinsmeister A. R., Carlson G. L., DiMagno E. P. Effect of a purified amylase inhibitor on carbohydrate tolerance in normal subjects and patients with diabetes mellitus. Mayo Clin Proc. 1986 Jun;61(6):442–447. doi: 10.1016/s0025-6196(12)61978-8. [DOI] [PubMed] [Google Scholar]
  19. Levitt N. S., Vinik A. I., Sive A. A., Van Tonder S., Lund A. Impaired pancreatic polypeptide responses to insulin-induced hypoglycemia in diabetic autonomic neuropathy. J Clin Endocrinol Metab. 1980 Mar;50(3):445–449. doi: 10.1210/jcem-50-3-445. [DOI] [PubMed] [Google Scholar]
  20. Lonovics J., Guzman S., Devitt P., Hejtmancik K. E., Suddith R. L., Rayford P. L., Thompson J. C. Release of pancreatic polypeptide in humans by infusion of cholecystokinin. Gastroenterology. 1980 Nov;79(5 Pt 1):817–822. [PubMed] [Google Scholar]
  21. Malagelada J. R., Rees W. D., Mazzotta L. J., Go V. L. Gastric motor abnormalities in diabetic and postvagotomy gastroparesis: effect of metoclopramide and bethanechol. Gastroenterology. 1980 Feb;78(2):286–293. [PubMed] [Google Scholar]
  22. Marshall J. J., Lauda C. M. Purification and properties of phaseolamin, an inhibitor of alpha-amylase, from the kidney bean, Phaseolus vulgaris. J Biol Chem. 1975 Oct 25;250(20):8030–8037. [PubMed] [Google Scholar]
  23. McConnell J. G., Alam M. J., O'Hare M. M., Buchanan K. D., Stout R. W. The effect of age and sex on the response of enteropancreatic polypeptides to oral glucose. Age Ageing. 1983 Feb;12(1):54–62. doi: 10.1093/ageing/12.1.54. [DOI] [PubMed] [Google Scholar]
  24. McGrath B. P., Stern A. I., Esler M., Hansky J. Impaired pancreatic polypeptide release to insulin hypoglycaemia in chronic autonomic failure with postural hypotension: evidence for parasympathetic dysfunction. Clin Sci (Lond) 1982 Sep;63(3):321–323. doi: 10.1042/cs0630321. [DOI] [PubMed] [Google Scholar]
  25. Meyer F. D., Gyr K., Häcki W. H., Beglinger C., Jeker L., Varga L., Kayasseh L., Gillessen D., Stalder G. A. The release of pancreatic polypeptide by CCK-octapeptide and some analogues in the dog. Gastroenterology. 1981 Apr;80(4):742–747. [PubMed] [Google Scholar]
  26. Polinsky R. J., Taylor I. L., Chew P., Weise V., Kopin I. J. Pancreatic polypeptide responses to hypoglycemia in chronic autonomic failure. J Clin Endocrinol Metab. 1982 Jan;54(1):48–52. doi: 10.1210/jcem-54-1-48. [DOI] [PubMed] [Google Scholar]
  27. Schwartz T. W., Holst J. J., Fahrenkrug J., Jensen S. L., Nielsen O. V., Rehfeld J. F., de Muckadell O. B., Stadil F. Vagal, cholinergic regulation of pancreatic polypeptide secretion. J Clin Invest. 1978 Mar;61(3):781–789. doi: 10.1172/JCI108992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Schwartz T. W., Rehfeld J. F., Stadil F., Larson L. I., Chance R. E., Moon N. Pancreatic-polypeptide response to food in duodenal-ulcer patients before and after vagotomy. Lancet. 1976 May 22;1(7969):1102–1105. doi: 10.1016/s0140-6736(76)90065-9. [DOI] [PubMed] [Google Scholar]
  29. Schwartz T. W., Rehfeld J. J. Mechanism of pancreatic-polypeptide release. Lancet. 1977 Mar 26;1(8013):697–698. doi: 10.1016/s0140-6736(77)92132-8. [DOI] [PubMed] [Google Scholar]
  30. Schwartz T. W., Stenquist B., Olbe L. Cephalic phase of pancreatic-polypeptide secretion studied by sham feeding in man. Scand J Gastroenterol. 1979;14(3):313–320. doi: 10.3109/00365527909179889. [DOI] [PubMed] [Google Scholar]
  31. Taylor I. L., Feldman M., Richardson C. T., Walsh J. H. Gastric and cephalic stimulation of human pancreatic polypeptide release. Gastroenterology. 1978 Sep;75(3):432–437. [PubMed] [Google Scholar]
  32. Taylor I. L., Impicciatore M., Carter D. C., Walsh J. H. Effect of atropine and vagotomy on pancreatic polypeptide response to a meal in dogs. Am J Physiol. 1978 Oct;235(4):E443–E447. doi: 10.1152/ajpendo.1978.235.4.E443. [DOI] [PubMed] [Google Scholar]
  33. Taylor I. L., Kauffman G. L., Jr, Walsh J. H., Trout H., Chew P., Harmon J. W. Role of the small intestine and gastric antrum in pancreatic polypeptide release. Am J Physiol. 1981 May;240(5):G387–G391. doi: 10.1152/ajpgi.1981.240.5.G387. [DOI] [PubMed] [Google Scholar]
  34. White N. H., Skor D. A., Cryer P. E., Levandoski L. A., Bier D. M., Santiago J. V. Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy. N Engl J Med. 1983 Mar 3;308(9):485–491. doi: 10.1056/NEJM198303033080903. [DOI] [PubMed] [Google Scholar]
  35. Williams R. R., Stegens N. L., Horm J. W. Patient interview study from the Third National Cancer Survey: overview of problems and potentials of these data. J Natl Cancer Inst. 1977 Mar;58(3):519–524. doi: 10.1093/jnci/58.3.519. [DOI] [PubMed] [Google Scholar]
  36. Wilson R. M., Boden G., Owen O. E. Pancreatic polypeptide responses to a meal and to intraduodenal amino acids and sodium oleate. Endocrinology. 1978 Mar;102(3):859–863. doi: 10.1210/endo-102-3-859. [DOI] [PubMed] [Google Scholar]
  37. Yoshiya K., Yamamura T., Ishikawa Y., Utsunomiya J., Mori K., Tsuda K., Seino Y. Effect of truncal vagotomy on intestinal phase of pancreatic polypeptide release in dogs. Regul Pept. 1985 Jun;11(2):143–148. doi: 10.1016/0167-0115(85)90074-6. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES